These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28781241)

  • 1. Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model.
    Foin N; Lu S; Ng J; Bulluck H; Hausenloy DJ; Wong PE; Virmani R; Joner M
    EuroIntervention; 2017 Oct; 13(9):e1096-e1098. PubMed ID: 28781241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
    Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic total occlusion is associated with a higher incidence of malapposition and uncovered stent struts: OCT findings at 6 months following DES implantation.
    Jia H; Hu S; Liu H; Zhu Y; Zhe CY; Li L; Mustafina I; Hou J; Zhang S; Yu B
    Catheter Cardiovasc Interv; 2017 Mar; 89(S1):582-591. PubMed ID: 28318139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stents.
    Bergheanu SC; Van der Hoeven BL; Hassan AK; Dijkstra J; Rosendaal FR; Liem SS; Schalij MJ; Van der Bom JG; Jukema JW
    Acta Cardiol; 2009 Oct; 64(5):611-6. PubMed ID: 20058506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCT analysis in patients with very late stent thrombosis.
    Kang SJ; Lee CW; Song H; Ahn JM; Kim WJ; Lee JY; Park DW; Lee SW; Kim YH; Mintz GS; Park SW; Park SJ
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):695-703. PubMed ID: 23643282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium (Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort).
    Adriaenssens T; Joner M; Godschalk TC; Malik N; Alfonso F; Xhepa E; De Cock D; Komukai K; Tada T; Cuesta J; Sirbu V; Feldman LJ; Neumann FJ; Goodall AH; Heestermans T; Buysschaert I; Hlinomaz O; Belmans A; Desmet W; Ten Berg JM; Gershlick AH; Massberg S; Kastrati A; Guagliumi G; Byrne RA;
    Circulation; 2017 Sep; 136(11):1007-1021. PubMed ID: 28720725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation.
    Izumi D; Miyahara M; Fujimoto N; Fukuoka S; Sakai M; Dohi K; Ito M
    Heart Vessels; 2016 Aug; 31(8):1247-56. PubMed ID: 26334709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
    Crimi G; Leonardi S; Costa F; Adamo M; Ariotti S; Valgimigli M
    Int J Cardiol; 2016 Jun; 212():110-7. PubMed ID: 27038714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Very Late Drug-Eluting Stent Thrombosis Assessed by Optical Coherence Tomography.
    Taniwaki M; Radu MD; Zaugg S; Amabile N; Garcia-Garcia HM; Yamaji K; Jørgensen E; Kelbæk H; Pilgrim T; Caussin C; Zanchin T; Veugeois A; Abildgaard U; Jüni P; Cook S; Koskinas KC; Windecker S; Räber L
    Circulation; 2016 Feb; 133(7):650-60. PubMed ID: 26762519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study.
    Kim JS; Hong MK; Fan C; Kim TH; Shim JM; Park SM; Ko YG; Choi D; Jang Y
    Am Heart J; 2010 Feb; 159(2):278-83. PubMed ID: 20152227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.
    Généreux P; Redfors B; Witzenbichler B; Maehara A; Yadav M; Weisz G; Francese DP; Parvataneni R; Brener SJ; Mehran R; Kirtane AJ; Stone GW
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):26-35. PubMed ID: 26813732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent malapposition, as a potential mechanism of very late stent thrombosis after bare-metal stent implantation: a case report.
    Higuma T; Abe N; Hanada K; Yokoyama H; Tomita H; Okumura K
    Cardiovasc Revasc Med; 2014 Apr; 15(3):178-81. PubMed ID: 24139450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a meta-analysis of randomized and observational Studies.
    Zimarino M; Corazzini A; Ricci F; Di Nicola M; De Caterina R
    JACC Cardiovasc Interv; 2013 Jul; 6(7):687-95. PubMed ID: 23769650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) - A comparative study.
    Chakraborty R; Patra S; Banerjee S; Pande A; Khan A; Mandol PC; Ghosh D; De SK; Das SS; Nag R
    Cardiovasc Revasc Med; 2016; 17(3):151-4. PubMed ID: 26905052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients.
    Tada T; Byrne RA; Simunovic I; King LA; Cassese S; Joner M; Fusaro M; Schneider S; Schulz S; Ibrahim T; Ott I; Massberg S; Laugwitz KL; Kastrati A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1267-74. PubMed ID: 24355117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stent malapposition generates stent thrombosis: Insights from a thrombosis model.
    Ng JCK; Lian SS; Zhong L; Collet C; Foin N; Ang HY
    Int J Cardiol; 2022 Apr; 353():43-45. PubMed ID: 35143874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.